NLS

Collaboration - December 19, 2017

More clinical-academic collaborations are in the future for Odense

With a new hospital being built near a university, more clinical-academic collaborations are in the future for Odense. The picturesque old town of Odense features the home of Hans Christian Andersen, the world-famous fairy tale writer from the 1800s. But only 10 km away, an ambitious, modern life sciences enterprise is developing. The New University Hospital […]

Business article - November 30, 2017

Antibiotic advances from New Drugs 4 Bad Bugs

Public-private partnerships are addressing the major challenges of microbial drug resistance. In 2016, a woman in the United States died from a bacterial strain resistant to 26 antibiotics. Recently, The Lancet reported on a dangerously resistant strain in China. The World Health Organization says that antimicrobial resistance (AMR) is a global emergency. Countering this worrying trend is the public-private program New Drugs 4 Bad Bugs […]

Science article - October 12, 2017

Spinning silk – without the spiders

Spider silk proteins have medical and research uses and are remarkably soluble. Spider silk is lightweight, strong, and nontoxic. It has biomedical applications in surgery, transplants, and as a matrix for culturing cells. The genes for spidroins, which are spider silk proteins, are known. Generating fibers is challenging, however. To make spider silk in vitro, […]

Profiles in Biotech - October 6, 2017

Next-generation biotech entrepreneurs

For young scientists and engineers, a startup can be part of early training and education.

Science article - July 7, 2017

Boosting CHO cell production with a systems approach

A new public resource for optimizing a common biofactory Biotherapeutic proteins including antibody therapies are often produced in Chinese hamster ovary (CHO) cells. A Cell Systems paper has novel insights about these cells and a new model for improving their productivity. The senior author is Nathan Lewis, who codirects systems research on CHO cells for […]

Biotech Business - June 16, 2017

Creating a more mature European biotech ecosystem

What can researchers, investors, and funding agencies do to unlock biotech’s potential? The European life science industry has great potential to improve patient care, solve public health challenges, and drive economic growth. Europe is a leader in life science research, but is behind the United States, in particular, in translating discoveries into medical therapies and […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.